Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Profit After Tax (2019 - 2025)

Outset Medical (OM) has disclosed Profit After Tax for 7 consecutive years, with -$19.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 24.05% to -$19.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$81.7 million, a 36.21% increase, with the full-year FY2025 number at -$81.7 million, up 36.21% from a year prior.
  • Profit After Tax was -$19.5 million for Q4 2025 at Outset Medical, down from -$17.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$17.8 million in Q3 2025 to a low of -$46.2 million in Q3 2023.
  • A 5-year average of -$33.9 million and a median of -$35.7 million in 2022 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 45.4% in 2021, then skyrocketed 46.19% in 2025.
  • Outset Medical's Profit After Tax stood at -$41.2 million in 2021, then fell by 0.62% to -$41.5 million in 2022, then increased by 6.89% to -$38.6 million in 2023, then soared by 33.52% to -$25.7 million in 2024, then rose by 24.05% to -$19.5 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Profit After Tax are -$19.5 million (Q4 2025), -$17.8 million (Q3 2025), and -$18.5 million (Q2 2025).